Literature DB >> 23294734

Transplantation of human umbilical cord blood or amniotic epithelial stem cells alleviates mechanical allodynia after spinal cord injury in rats.

Dae-Hyun Roh1, Min-Soo Seo, Hoon-Seong Choi, Sang-Bum Park, Ho-Jae Han, Alvin J Beitz, Kyung-Sun Kang, Jang-Hern Lee.   

Abstract

Stem cell therapy is a potential treatment for spinal cord injury (SCI), and a variety of different stem cell types have been grafted into humans suffering from spinal cord trauma or into animal models of spinal injury. Although several studies have reported functional motor improvement after transplantation of stem cells into injured spinal cord, the benefit of these cells for treating SCI-induced neuropathic pain is not clear. In this study, we investigated the therapeutic effect of transplanting human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) or amniotic epithelial stem cells (hAESCs) on SCI-induced mechanical allodynia (MA) and thermal hyperalgesia (TH) in T13 spinal cord hemisected rats. Two weeks after SCI, hUCB-MSCs or hAESCs were transplanted around the spinal cord lesion site, and behavioral tests were performed to evaluate changes in SCI-induced MA and TH. Immunohistochemical and Western blot analyses were also performed to evaluate possible therapeutic effects on SCI-induced inflammation and the nociceptive-related phosphorylation of the NMDA NR1 receptor subunit. While transplantation of hUCB-MSCs showed a tendency to reduce MA, transplantation of hAESCs significantly reduced MA. Neither hUCB-MSC nor hAESC transplantation had any effect on SCI-induced TH. Transplantation of hAESCs also significantly reduced the SCI-induced increase in NMDA receptor NR1 subunit phosphorylation (pNR1) expression in the spinal cord. Both hUCB-MSCs and hAESCs reduced the SCI-induced increase in spinal cord expression of the microglial marker, F4/80, but not the increased expression of GFAP or iNOS. Taken together, these findings demonstrate that the transplantation of hAESCs into the injured spinal cord can suppress mechanical allodynia, and this effect seems to be closely associated with the modulation of spinal cord microglia activity and NR1 phosphorylation.

Entities:  

Mesh:

Year:  2013        PMID: 23294734     DOI: 10.3727/096368912X659907

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  26 in total

Review 1.  Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?

Authors:  John Bianco; Pauline De Berdt; Ronald Deumens; Anne des Rieux
Journal:  Cell Mol Life Sci       Date:  2016-01-14       Impact factor: 9.261

2.  miR-410 Inhibition Induces RPE Differentiation of Amniotic Epithelial Stem Cells via Overexpression of OTX2 and RPE65.

Authors:  Soon Won Choi; Jae-Jun Kim; Min-Soo Seo; Sang-Bum Park; Tae-Wook Kang; Jin Young Lee; Byung-Chul Lee; Insung Kang; Tae-Hoon Shin; Hyung-Sik Kim; Kyung-Rok Yu; Kyung-Sun Kang
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

Review 3.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

4.  BDNF-hypersecreting human umbilical cord blood mesenchymal stem cells promote erectile function in a rat model of cavernous nerve electrocautery injury.

Authors:  Lujie Song; Jianqiang Zhu; Xiong Zhang; Zhiqiang Cui; Qiang Fu; Jianwen Huang; Hongkai Lu
Journal:  Int Urol Nephrol       Date:  2015-11-17       Impact factor: 2.370

5.  HAEC in the treatment of brain hemorrhage: a preliminary observation in rabbits.

Authors:  Heping Zhou; Zhaohui Mu; Xinsheng Chen; Zhengsheng Shi; Zhengjiang Zha; Yanfei Liu; Zheng Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  [Effects of hypoxia-inducible factor 1α on hypoxic tolerance of human amniotic mesenchymal stem cells].

Authors:  Lihao Ge; Deshui Yu; Ruichao Su; Yang Cao
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2018-03-15

7.  Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells.

Authors:  Phuc Van Pham; Ngoc Bich Vu; Vuong Minh Pham; Nhung Hai Truong; Truc Le-Buu Pham; Loan Thi-Tung Dang; Tam Thanh Nguyen; Anh Nguyen-Tu Bui; Ngoc Kim Phan
Journal:  J Transl Med       Date:  2014-02-24       Impact factor: 5.531

Review 8.  Cell therapy and delivery strategies for spinal cord injury.

Authors:  Bruna Dos S Ramalho; Fernanda M de Almeida; Ana M B Martinez
Journal:  Histol Histopathol       Date:  2021-06-10       Impact factor: 2.303

9.  Human amnion mesenchymal cells inhibit lipopolysaccharide-induced TNF-α and IL-1β production in THP-1 cells.

Authors:  Jun Shu; Xiaojuan He; Lan Zhang; Hong Li; Ping Wang; Xiaojie Huang
Journal:  Biol Res       Date:  2015-12-23       Impact factor: 5.612

Review 10.  Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application.

Authors:  Carmen L Insausti; Miguel Blanquer; Ana M García-Hernández; Gregorio Castellanos; José M Moraleda
Journal:  Stem Cells Cloning       Date:  2014-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.